The UNIFLECA study. prospective cohort study on flecainide impact on persistent high premature ventricular contraction burden and induced cardiomyopathy

Back

EHRA Premium Access

The UNIFLECA study. prospective cohort study on flecainide impact on persistent high premature ventricular contraction burden and induced cardiomyopathy

Session: ECG and rhythm monitoring

Topic: Antiarrhythmic Drug Treatment

Speaker: Doctor S. Kotoulas (Athens, GR)

Event: EHRA 2025

Congress Presentation

Add to my library

About the speaker

Doctor Sotirios Kotoulas

Asklepieion Voulas General Hospital, Athens (Greece)

0 follower

6 more presentations in this session

Electrocardiographical features in patients with bidirectional ventricular tachycardia

Speaker: Doctor R. Vazirani Ballesteros (Madrid, ES)

Lateral wall repolarization in standard ECG as a criterion to democratize conduction system pacing

Speaker: Doctor D. Fakim (Shebrooke, CA)

QRS-microfragmentation and non-planarity as predictors of clinical outcome and left ventricular ejection fraction improvement following cardiac resychronization therapy

Speaker: Doctor M. Blondeel (Leuven, BE)

Rationale and design of the RISC trial: a multicenter RCT to assess in hospital 24 hour observation with telemetry of syncope patients admitted to the cardiac emergency room and emergency department

Speaker: Mr T. Boel (Amsterdam, NL)

Detailed analysis of PAC characteristics in ambulatory ECG data can improve atrial fibrillation risk prediction

Speaker: Doctor N. Van Vreeswijk (Groningen, NL)

Access the full session

ECG and rhythm monitoring

Speakers: Doctor S. Kotoulas, Doctor R. Vazirani Ballesteros, Doctor D. Fakim, Doctor M. Blondeel, Mr T. Boel...

Access

About the event

EHRA 2025

30 March - 1 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources